Inovio Pharma buy Oppenheimer Holdings Inc.
Start price
25.01.24
/
50%
€0.53
Target price
25.01.25
€3.68
Performance (%)
-
End price
26.01.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Inovio Pharma | - | - | - |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Inovio Pharma diskutieren
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $4.00 price target on the stock.
Ratings data for INO provided by MarketBeat
In the thread Trading Inovio Pharma
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten